 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Denali Therapeutics Inc. (DNLI)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-30 Sale | 2020-04-01 6:19 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 1,428 | $19.48 | $27,817 | 1,006,488 (Direct) | View |
| 2020-06-05 Sale | 2020-06-09 4:10 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 1,922,855 | $25.75 | $49,513,516 | 13,644,881 (Indirect) | View |
| 2020-06-16 Sale | 2020-06-18 9:41 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 400,000 | $26.1 | $10,440,000 | 2,739,043 (Direct) | View |
| 2020-06-19 Sale | 2020-06-23 5:41 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 255,000 | $24.72 | $6,304,373 | 698,035 (Indirect) | View |
| 2020-06-26 Sale | 2020-06-30 7:17 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 250,000 | $23.97 | $5,993,052 | 448,035 (Indirect) | View |
| 2020-08-12 Sale | 2020-08-14 4:50 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 1,443,247 | $31.65 | $45,678,767 | 12,201,634 (Indirect) | View |
| 2020-09-10 Sale | 2020-09-14 9:38 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 3,689 | $31 | $114,359 | 165,141 (Indirect) | View |
| 2020-10-08 Sale | 2020-10-13 6:45 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 52,906 | $40.74 | $2,155,603 | 166,617 (Indirect Direct) | View |
| 2020-11-04 Sale | 2020-11-06 5:53 pm | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 10,000 | $50.18 | $501,830 | 65,000 (Indirect Direct) | View |
| 2020-11-10 Sale | 2020-11-12 4:21 pm | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 10,000 | $60.03 | $600,310 | 55,000 (Indirect Direct) | View |
| 2020-11-12 Sale | 2020-11-13 5:13 pm | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 30,000 | $70.05 | $2,101,590 | 25,000 (Indirect Direct) | View |
| 2018-11-15 Sale(A) | 2020-11-30 6:12 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 17,500 | $18.07 | $316,157 | 178,125 (Indirect Direct) | View |
| 2018-12-03 Sale(A) | 2020-11-30 6:13 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 17,500 | $18.45 | $322,834 | 178,125 (Indirect Direct) | View |
| 2019-01-02 Sale(A) | 2020-11-30 6:14 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 17,500 | $19.44 | $340,168 | 178,125 (Indirect Direct) | View |
| 2020-12-11 Sale | 2020-12-15 4:47 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 64,624 | $80.14 | $5,179,285 | 383,411 (Indirect) | View |
| 2020-12-21 Sale | 2020-12-23 9:52 pm | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 30,000 | $90.05 | $2,701,582 | 26,232 (Indirect Direct) | View |
| 2021-01-04 Sale | 2021-01-06 6:49 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 88,334 | $74.96 | $6,621,782 | 2,322,978 (Indirect Direct) | View |
| 2021-01-04 Sale | 2021-01-06 6:50 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 70,000 | $74.95 | $5,246,409 | 544,562 (Indirect Direct) | View |
| 2021-01-15 Sale | 2021-01-20 6:46 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 50,000 | $71.45 | $3,572,556 | 950,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-06-03 Option Award | 2020-06-05 5:58 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:58 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:59 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:59 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:00 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:00 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:00 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:00 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:01 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | Klein Peter S Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:01 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Klein Peter S Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:02 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | NELSEN ROBERT Director 10% Owner | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:02 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | NELSEN ROBERT Director 10% Owner | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:02 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:02 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:03 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:03 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-18 Gift | 2020-06-18 9:42 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 40,000 | $0 | 2,389,304 (Indirect) | View |
| 2020-08-18 Option Award | 2020-08-20 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-08-18 Option Award | 2020-08-20 6:17 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-08-18 Option Award | 2020-08-20 6:19 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-08-18 Option Award | 2020-08-20 6:20 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-08-20 Exercise | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 5,643 | $0 | 0 (Indirect) | View |
| 2020-08-20 Tax Withholding | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 1,954 | $32.87 | 0 (Indirect) | View |
| 2020-08-20 Exercise | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 5,643 | $0 | 0 (Direct) | View |
| 2020-08-20 Exercise | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 5,643 | $0 | 0 (Indirect) | View |
| 2020-08-20 Tax Withholding | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 1,954 | $32.88 | 0 (Indirect) | View |
| 2020-08-20 Exercise | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 5,643 | $0 | 0 (Direct) | View |
| 2020-08-20 Exercise | 2020-08-24 8:38 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 5,643 | $0 | 0 (Direct) | View |
| 2020-08-20 Tax Withholding | 2020-08-24 8:38 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 1,954 | $32.88 | 0 (Direct) | View |
| 2020-08-20 Exercise | 2020-08-24 8:38 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 5,643 | $0 | 0 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-13 6:45 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 22,906 | $5.28 | 166,617 (Indirect) | View |
| 2020-10-08 Exercise | 2020-10-13 6:45 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 30,000 | $5.28 | 166,617 (Indirect) | View |
| 2020-10-08 Exercise | 2020-10-13 6:45 pm | N/A 2026-07-01 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 13,020 | $5.28 | 166,617 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-13 6:45 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 9,886 | $5.28 | 166,617 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-13 6:45 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 30,000 | $5.28 | 166,617 (Direct) | View |
| 2020-08-20 Exercise | 2020-11-30 6:11 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 5,643 | $0 | 614,562 (Indirect) | View |
| 2020-08-20 Tax Withholding | 2020-11-30 6:11 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 1,954 | $32.88 | 614,562 (Indirect) | View |
| 2018-11-15 Exercise | 2020-11-30 6:12 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 12,235 | $5.28 | 178,125 (Indirect) | View |
| 2018-11-15 Exercise | 2020-11-30 6:12 pm | N/A 2026-07-01 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 12,235 | $5.28 | 178,125 (Direct) | View |
| 2018-12-03 Exercise | 2020-11-30 6:13 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 17,500 | $5.28 | 178,125 (Indirect) | View |
| 2018-12-03 Exercise | 2020-11-30 6:13 pm | N/A 2026-07-01 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 17,500 | $5.28 | 178,125 (Direct) | View |
| 2019-01-02 Exercise | 2020-11-30 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 5,775 | $5.28 | 178,125 (Indirect) | View |
| 2019-01-02 Exercise | 2020-11-30 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 5,775 | $5.28 | 178,125 (Indirect) | View |
| 2019-01-02 Exercise | 2020-11-30 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 5,950 | $5.28 | 178,125 (Indirect) | View |
| 2019-01-02 Exercise | 2020-11-30 6:14 pm | N/A 2026-07-01 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 5,775 | $5.28 | 178,125 (Direct) | View |
| 2019-01-02 Exercise | 2020-11-30 6:14 pm | N/A 2026-07-01 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 5,775 | $5.28 | 178,125 (Direct) | View |
| 2019-01-02 Exercise | 2020-11-30 6:14 pm | N/A 2026-07-01 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 5,950 | $5.28 | 178,125 (Direct) | View |
| 2020-12-21 Other | 2020-12-23 6:44 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 383,411 | $0 | 0 (Indirect) | View |
| 2021-01-04 Option Award | 2021-01-06 6:49 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 60,000 | $0 | 2,322,978 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 6:49 pm | N/A 2031-01-03 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 180,000 | $70.86 | 2,322,978 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 6:50 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 30,000 | $0 | 544,562 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 6:50 pm | N/A 2031-01-03 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 90,000 | $70.86 | 544,562 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 6:54 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 30,000 | $0 | 90,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 6:54 pm | N/A 2031-01-03 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 90,000 | $70.86 | 90,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 6:55 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 30,000 | $0 | 90,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 6:55 pm | N/A 2031-01-03 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 90,000 | $70.86 | 90,000 (Direct) | View |
| 2021-01-08 Option Award | 2021-01-12 6:44 pm | N/A 2031-01-07 | Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director | 7,535 | $80.03 | 2,511 (Direct) | View |
| 2021-01-08 Option Award | 2021-01-12 6:44 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director | 2,511 | $0 | 2,511 (Direct) | View |